{
    "title": "Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11727149/Teva-Pharmaceutical-meets-Q4-profit-estimates-sees-flat-2023.html",
    "date": "2023-02-08",
    "keywords": [
        "year",
        "teva",
        "revenue",
        "francis",
        "share",
        "ajovy",
        "growth",
        "scheer",
        "forecast",
        "austedo",
        "treatment",
        "case",
        "strategy",
        "company",
        "debt",
        "jerusalem",
        "drugmaker",
        "profit",
        "result",
        "midday",
        "richard",
        "officer",
        "start",
        "conference",
        "call",
        "pipeline",
        "opportunity",
        "market",
        "wednesday",
        "biosimilar",
        "arthritis",
        "humira",
        "july",
        "approval",
        "living",
        "goal",
        "shareholder",
        "value",
        "exclusivity",
        "blockbuster",
        "sclerosis",
        "drug",
        "copaxone",
        "drop",
        "spate",
        "period",
        "line",
        "dollar",
        "refinitiv",
        "end",
        "ability",
        "wont",
        "intensive",
        "quarter",
        "product",
        "reporting",
        "editing",
        "rabinovitch",
        "elaine",
        "hardcastle",
        "sharon",
        "singleton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}